Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › WI › MENOMONEE FALLS › COMMUNITY MEMORIAL HOSPITAL OF MENOMONEE FALLS INC

COMMUNITY MEMORIAL HOSPITAL OF MENOMONEE FALLS INC

NPI: 1609822881 · MENOMONEE FALLS, WI 53051 · Adult Mental Health Clinic/Center · NPI assigned 05/26/2006

$10.09M
Total Medicaid Paid
577,626
Total Claims
437,449
Beneficiaries
243
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialLUX, TERESA (PRESIDENT)
NPI Enumeration Date05/26/2006

Related Entities

Other providers sharing the same authorized official: LUX, TERESA

ProviderCityStateTotal Paid
COMMUNITY MEMORIAL HOSPITAL OF MENOMONEE FALLS, INC MENOMONEE FALLS WI $190K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 68,106 $1.30M
2019 77,439 $1.40M
2020 78,292 $1.39M
2021 82,993 $1.43M
2022 88,090 $1.42M
2023 102,210 $1.68M
2024 80,496 $1.48M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 28,973 25,255 $1.58M
96361 Intravenous infusion, hydration; each additional hour 13,016 9,679 $1.40M
99284 Emergency department visit for the evaluation and management, high severity 20,971 17,953 $1.03M
80053 Comprehensive metabolic panel 19,706 15,630 $505K
80048 Basic metabolic panel (calcium, ionized) 22,965 16,902 $423K
74177 Computed tomography, abdomen and pelvis; with contrast material 5,393 4,773 $361K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 6,357 4,103 $316K
70450 Computed tomography, head or brain; without contrast material 5,570 4,951 $315K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 4,079 3,430 $244K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 3,245 2,848 $213K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 3,275 1,620 $211K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 1,818 1,658 $177K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3,936 3,279 $176K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 33,590 25,370 $176K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 2,650 2,304 $152K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 4,811 2,906 $145K
71275 Computed tomographic angiography, chest, with contrast material 1,902 1,711 $139K
G0378 Hospital observation service, per hour 5,839 4,832 $127K
84484 14,154 7,534 $101K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 3,296 2,930 $94K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 3,303 2,935 $88K
74176 Computed tomography, abdomen and pelvis; without contrast material 1,584 1,409 $86K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 4,887 1,904 $85K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,417 1,271 $84K
81025 9,250 7,941 $78K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 1,875 1,612 $77K
88305 Level IV - Surgical pathology, gross and microscopic examination 6,228 2,434 $63K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 679 625 $56K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 856 476 $56K
83880 2,743 2,371 $51K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1,402 1,030 $50K
85610 6,058 4,337 $49K
83690 9,210 7,594 $48K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1,169 661 $45K
81001 12,416 10,793 $43K
82962 8,408 4,203 $43K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 870 768 $42K
83735 9,763 6,847 $40K
72125 Computed tomography, cervical spine; without contrast material 1,883 1,684 $39K
87086 Culture, bacterial; quantitative colony count, urine 4,952 4,377 $37K
87077 3,078 2,699 $34K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1,714 1,557 $32K
85027 6,790 4,960 $30K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 569 350 $29K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 786 720 $29K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 1,234 500 $28K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography 391 343 $28K
84443 Thyroid stimulating hormone (TSH) 2,830 2,476 $28K
96367 546 376 $27K
76705 Ultrasound, abdominal, real time with image documentation; limited 946 859 $26K
97530 Therapeutic activities, direct patient contact, each 15 minutes 2,973 1,143 $25K
84702 1,648 1,360 $24K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 214 190 $23K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 2,041 1,765 $23K
97162 1,167 924 $22K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 953 375 $22K
80076 3,838 3,312 $22K
85379 2,939 2,599 $21K
83605 2,631 2,123 $20K
93971 884 804 $19K
87210 2,756 2,459 $19K
80143 1,362 1,130 $18K
76830 Ultrasound, transvaginal 717 635 $18K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 3,247 2,244 $18K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,223 1,089 $17K
71260 Computed tomography, thorax, diagnostic; with contrast material 320 281 $17K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 217 197 $16K
70551 Magnetic resonance imaging, brain; without contrast material 363 323 $16K
82077 1,553 1,306 $15K
87081 1,138 1,030 $15K
87088 2,436 2,204 $14K
87040 2,441 1,048 $14K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 108 94 $13K
80179 1,327 1,103 $13K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 75 66 $13K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 324 268 $13K
87186 2,327 2,015 $13K
97116 1,790 835 $11K
80061 Lipid panel 1,091 997 $11K
82728 964 817 $10K
82805 465 405 $10K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 15,383 12,744 $9K
71046 Radiologic examination, chest; 2 views 5,933 5,337 $9K
87275 373 343 $9K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 9,273 5,062 $9K
97535 Self-care/home management training, each 15 minutes 1,709 904 $9K
97161 422 342 $9K
82607 575 519 $9K
86850 1,061 892 $8K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 18,227 15,037 $7K
76642 209 178 $7K
84100 2,690 1,742 $6K
70496 67 61 $6K
81003 2,432 2,174 $6K
71045 Radiologic examination, chest; single view 8,629 7,536 $5K
85730 1,381 1,226 $5K
70498 54 49 $5K
80050 General health panel 746 610 $5K
87276 373 343 $5K
82550 1,090 854 $4K
86140 1,086 854 $4K
97166 416 295 $4K
86900 1,788 1,523 $4K
87070 385 300 $4K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 69 61 $4K
83615 1,128 729 $3K
83036 Hemoglobin; glycosylated (A1C) 512 455 $3K
96375 Therapeutic injection; each additional sequential IV push 10,999 8,658 $3K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 52 41 $3K
93976 102 84 $3K
84439 379 314 $3K
86901 1,279 1,113 $3K
93017 130 111 $3K
12001 26 25 $2K
97165 131 106 $2K
71250 88 81 $2K
82565 133 120 $2K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 437 381 $2K
76801 374 326 $2K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 66 55 $2K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 30 29 $2K
73630 815 730 $2K
72131 75 66 $2K
84550 818 524 $2K
74183 16 12 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 9,469 8,010 $2K
70486 61 54 $2K
82150 54 39 $2K
96376 4,581 2,922 $1K
73560 1,681 1,450 $1K
83550 254 226 $1K
90715 209 203 $1K
84703 146 129 $1K
99215 Prolong outpt/office vis 20 18 $1K
77065 Tomosynthesis, mammo 169 144 $1K
83540 263 235 $1K
77061 71 63 $1K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 353 309 $785.50
87205 346 281 $753.47
77063 Screening digital breast tomosynthesis, bilateral 28 26 $724.34
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 25 15 $683.67
36415 Collection of venous blood by venipuncture 9,424 5,231 $669.14
36591 1,260 745 $662.49
85007 386 295 $625.74
73610 594 546 $617.61
84145 38 27 $567.67
82950 176 172 $537.97
Q3014 Telehealth originating site facility fee 100 64 $498.49
G0103 Prostate cancer screening; prostate specific antigen test (psa) 30 26 $438.99
72128 15 13 $434.41
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 14 13 $431.08
83970 14 13 $429.04
90686 42 39 $425.12
J1170 Injection, hydromorphone, up to 4 mg 4,968 3,176 $419.00
82570 86 84 $390.89
36000 313 286 $386.30
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 13 12 $332.63
85652 198 175 $330.49
73030 718 648 $325.61
86592 15 15 $322.74
82746 26 26 $316.77
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg 204 182 $316.14
85045 87 67 $279.11
J2405 Injection, ondansetron hydrochloride, per 1 mg 11,675 8,653 $277.14
J1885 Injection, ketorolac tromethamine, per 15 mg 10,598 8,301 $252.53
77067 Screening mammography, bilateral, including computer-aided detection 28 26 $238.05
84156 67 66 $222.93
87075 51 43 $217.34
73130 317 276 $212.97
36416 4,842 2,637 $171.83
82330 13 12 $162.71
G0008 Administration of influenza virus vaccine 181 152 $158.15
73502 216 194 $150.49
J1650 Injection, enoxaparin sodium, 10 mg 2,909 1,010 $135.07
80164 15 13 $127.07
88342 26 25 $123.40
J3010 Injection, fentanyl citrate, 0.1 mg 6,873 5,429 $121.28
J1200 Injection, diphenhydramine hcl, up to 50 mg 3,329 2,631 $102.31
82947 35 32 $99.99
J3475 Injection, magnesium sulfate, per 500 mg 1,658 932 $98.85
J0696 Injection, ceftriaxone sodium, per 250 mg 2,783 1,922 $95.34
74018 148 113 $79.04
73110 56 52 $73.22
J2270 Injection, morphine sulfate, up to 10 mg 2,876 2,185 $60.21
88304 33 25 $52.62
72100 29 28 $52.45
C9113 Injection, pantoprazole sodium, per vial 445 269 $51.43
73090 20 13 $38.36
J2704 Injection, propofol, 10 mg 4,782 2,891 $35.64
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 3,068 1,157 $28.21
P9612 Catheterization for collection of specimen, single patient, all places of service 350 311 $27.45
J2060 Injection, lorazepam, 2 mg 1,376 1,067 $22.98
A9585 Injection, gadobutrol, 0.1 ml 1,895 1,675 $22.59
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 1,683 992 $20.32
85018 19 16 $12.49
85014 20 17 $12.49
J0780 Injection, prochlorperazine, up to 10 mg 638 499 $9.48
J0690 Injection, cefazolin sodium, 500 mg 3,725 2,357 $8.74
J0330 Injection, succinylcholine chloride, up to 20 mg 44 27 $8.32
J0171 Injection, adrenalin, epinephrine, 0.1 mg 283 245 $7.30
Q9956 Injection, octafluoropropane microspheres, per ml 641 546 $7.14
J1100 Injection, dexamethasone sodium phosphate, 1 mg 5,006 3,913 $4.79
J1644 Injection, heparin sodium, per 1000 units 1,829 565 $4.59
J7120 Ringers lactate infusion, up to 1000 cc 1,559 1,097 $4.39
J2250 Injection, midazolam hydrochloride, per 1 mg 4,842 3,960 $2.36
J2919 Injection, methylprednisolone sodium succinate, 5 mg 34 26 $2.03
J1790 Injection, droperidol, up to 5 mg 575 487 $1.09
J3370 Injection, vancomycin hcl, 500 mg 308 209 $0.83
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 1,635 1,318 $0.65
J2765 Injection, metoclopramide hcl, up to 10 mg 2,258 1,823 $0.65
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 1,245 808 $0.03
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 136 134 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 429 336 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 371 302 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 144 112 $0.00
51798 14 13 $0.00
C1769 Guide wire 91 78 $0.00
J1630 Injection, haloperidol, up to 5 mg 14 13 $0.00
J8540 Dexamethasone, oral, 0.25 mg 65 40 $0.00
J1940 Injection, furosemide, up to 20 mg 118 54 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 19 13 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 388 268 $0.00
J2785 Injection, regadenoson, 0.1 mg 58 51 $0.00
J3411 Injection, thiamine hcl, 100 mg 57 38 $0.00
J0500 Injection, dicyclomine hcl, up to 20 mg 15 12 $0.00
J8501 Aprepitant, oral, 5 mg 14 12 $0.00
72170 27 26 $0.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 16 12 $0.00
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose 17 15 $0.00
0352U 15 14 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 16 12 $0.00
C1776 Joint device (implantable) 125 110 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 170 137 $0.00
51702 13 12 $0.00
J1171 Injection, hydromorphone, 0.1 mg 95 67 $0.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 109 95 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 584 469 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 33 24 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 13 13 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 28 24 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 15 14 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 35 26 $0.00
73590 17 12 $0.00